Prof Monica Slavin
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
571 Scholarly works
28 Projects
HIGHLIGHTS
2026
Journal article
International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients.
DOI: 10.1111/tid.702332026
Journal article
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.
DOI: 10.1016/j.jtct.2026.03.0402026
Journal article
Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
DOI: 10.1136/bmjopen-2025-1111942024
Research grants (ARC, NHMRC, MRFF)
Transforming Infection Management in the Era of Emerging Cancer Therapies
2022
Journal article
Cost-effectiveness of home-based care of febrile neutropenia in children with cancer
DOI: 10.1002/pbc.294692022
Research grants (other domestic)
Appropriate Antimicrobial Use: Scaling Surveillance Using Digital Health
2022
Research grants (ARC, NHMRC, MRFF)
Improving Patient Outcomes Through Implementation of Digital and Diagnostic Innovations for Infections in Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis
DOI: 10.1016/j.cmi.2026.01.0302026
Journal article
Invasive mould infection in children – advances made or obstacles remaining?
DOI: 10.1016/j.cmi.2025.11.0232026
Journal article
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies.
DOI: 10.1182/bloodadvances.20250195632026
Journal article
Diagnosis and risk factors for invasive mould disease—a round table discussion on directing antifungal therapy according to the available evidence
DOI: 10.1093/jac/dkag0622026
Journal article
25 years of improvement in mortality in invasive aspergillosis in haematology patients: Will it be sustained or is it under threat?
DOI: 10.1093/jac/dkag0772026
Journal article
Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study
DOI: 10.1093/jac/dkag1182026
Journal article
Message from the incoming Editor-in-Chief of JAC
DOI: 10.1093/jac/dkaf479
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
MITIGATE: Metagenomics and Integrated Transcriptomics for Infectious Disease Genomics and Translational Evaluation